Regulatory Science Symposium: Bringing Drugs and Biologics to Market - Session 4: "Safety Reporting"

Regulatory & Quality Sciences
Research & Study Conduct

Regulatory Science Symposium: Bringing Drugs and Biologics to Market - Session 3: "Combination and Innovative Products"

Regulatory & Quality Sciences
Research & Study Conduct

Regulatory Science Symposium: Bringing Drugs and Biologics to Market - Session 1: "Welcome"

Regulatory & Quality Sciences
Research & Study Conduct

Regulatory Science Symposium: "Ensuring Clinical Trial Compliance" Session 7 - Wrap-up

Regulatory & Quality Sciences
Study & Site Management
Research & Study Conduct

Regulatory Science Symposium: "Ensuring Clinical Trial Compliance" Session 6 - Bioresearch Monitoring Program (BIMO), Good Clinical Practice Inspections, Compliance and Warning Letters

Regulatory & Quality Sciences
Study & Site Management
Research & Study Conduct

Regulatory Science Symposium: "Ensuring Clinical Trial Compliance" Session 5 - Good Distribution Practices: Application of supply chain management and quality management systems

Regulatory & Quality Sciences
Study & Site Management
Research & Study Conduct

Regulatory Science Symposium: "Ensuring Clinical Trial Compliance" Session 4 - Good Clinical Practice for Site Audits

Regulatory & Quality Sciences
Study & Site Management
Research & Study Conduct

Regulatory Science Symposium: "Ensuring Clinical Trial Compliance" Session 3 - Sponsor Audits: Data Handling and Reports

Regulatory & Quality Sciences
Study & Site Management
Research & Study Conduct

NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

This program is open to all eligible individuals. SC CTSI operates all of its programs and activities consistent with the University’s Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation, or any other prohibited factor.

For our complete Terms of Use, including privacy and legal compliance statements, click HERE.